| Sales | 3,400.6a | 3,127.5a |
| Other revenues | 173.9a | 178.9a |
| Revenue | 3,574.5a | 3,306.4a |
| Cost of goods sold | -618.7a | -571.2a |
| Selling expenses | -957.2a | -917.1a |
| Research and development expenses | -686.6a | -619.3a |
| General and administrative expenses | -216.3a | -217.8a |
| Other operating income | 120.6a | 62.6a |
| Other operating expenses | -424.7a | -453.3a |
| Restructuring costs | -14.1a | -27.7a |
| Impairment losses | -280.9a | -253.4a |
| Operating income | 496.7a | 816a |
| Net financing costs | -8.6a | -19.4a |
| Other financial income and expenses | -56.4a | -35.1a |
| Income taxes | -74.9a | -136.2a |
| Share of net profit/(loss) from equity-accounted companies | 0.5a | -5.4a |
| Net profit/(loss) from continuing operations | 357.3a | 619.9a |
| Net profit/(loss) from discontinued operations | -10a | 27.3a |
| Consolidated net profit | 347.3a | 647.2a |
| Attributable to shareholders of Ipsen S.A. | 345.9a | 644.4a |
| Attributable to non-controlling interests | 1.4a | 2.8a |